Citations

Clear

9 citation(s) found for "Martin, Elizabeth".

Abstract 5078: Sustained Acting Atrial Natriuretic Peptide: A Novel Natriuretic Peptide With Potent Blood Pressure Lowering and Renal Enhancing Properties in a Canine Model of Acute Angiotensin Induced Hypertension
Boerrigter, Guido, Chen, Horng, Martin, F. Elizabeth , McKie, Paul M. , Cataliotti, Alessandro , Burnett, John

Mayo Clinic

Circulation | April 23, 2024 | Volume: 120 | Issue: suppl_18 | Pages: No page available

10.1161/circ.120.suppl_18.s1045 Get It

Background Sustained Acting Atrial Natriuretic Peptide (SA-ANP) is a 40 AA peptide consisting of native ANP (1–28) with a 12 AA C-terminus extension which we synthesized based upon a familial ANP gene frameshift mutation. SA-ANP possesses markedly greater and more sustained mean arterial pressure (MAP) lowering, diuretic/natriuretic, angiotensin-aldosterone suppressing, and cGMP activating properties compared to ANP in normal dogs consistent with a super agonist of the ANP receptor (NPR-A) ( JACC in press ). Here we evaluated SA-ANP in a model of acute hypertension with the hypothesis that SA-ANP would have potent MAP lowering and renal enhancing properties. Methods Integrated physiological studies were performed in a canine model of ANG induced hypertension (20 ng/kg/min continuous infusion) before, during, and up to 3 hours following a 45 minute infusion of SA-ANP (30 pmol/kg/min) (n=6) or vehicle (n=6). Results MAP is shown in Figure 1 . SVR significantly decreased and despite a significant reduction in MAP both renal blood flow (RBF) and GFR were significantly increased following SA-ANP infusion. There were significant reductions in proximal and distal tubule sodium reabsorption resulting in a significant increase (>50 fold) in diuresis and natriuresis with SA-ANP. These renal actions were associated with significant increases in plasma and urine cGMP and a significant inhibition of aldosterone activation. Discussion We report for the first time in an acute model of hypertension that SA-ANP reduced MAP while enhancing RBF, GFR, and sodium/water excretion and thus may serve as a potential therapeutic agent in the treatment of hypertension in the setting of volume overload.
Glioma-Related Seizures: Beyond Glioma Grade and Histopathology (S3.002)
Tatum, William O. , Vilanilam, George C. , Taner, Nilüfer, Rosenfeld, Steven S. , Jentoft, Mark E. , Younkin, Mariet, Martin, Elizabeth C. , Yelvington, Kirsten , Quiñones‐Hinojosa, Alfredo , Feyissa, Anteneh M. , Worrell, Gregory A. , Guerrero‐Cazares, Hugo , Martin, Elizabeth

Mayo Clinic

Neurology | December 7, 2023 | Volume: 92 | Issue: 15_supplement | Pages: No page available

10.1212/wnl.92.15_supplement.s3.002 Get It

Transcriptional landscape of human microglia implicates age, sex, and APOE‐related immunometabolic pathway perturbations
Patel, Tulsi , Carnwath, Troy , Wang, Xue , Allen, Mariet , Lincoln, Sarah, Lewis‐Tuffin, Laura J. , Quicksall, Zachary , Lin, Shu, Tutor‐New, Frederick Q, Ho, Charlotte C.G. , Min, Yuhao , Malphrus, Kimberly G., Nguyen, Thuy , Martin, Elizabeth, Al‐kharboosh, Rawan , Chaichana, Kaisorn L. , Wharen, Robert E. , Guerrero‐Cazares, Hugo , Quiñones‐Hinojosa, Alfredo , Ertekin‐Taner, Nilüfer , Carnwath, Troy P, Lincoln, Sarah J, Quicksall, Zachary S, Garcia, César A. , Alkharboosh, Rawan M, Chaichana, Kaisorn, Wharen, Robert, Ertekin-Taner, Nilüfer , Guerrero-Cazares, Hugo , Grewal, Sanjeet S.

Mayo Clinic

Aging Cell | April 7, 2022 | Volume: 21 | Issue: 5 | Pages: No page available

10.1111/acel.13606 | PMID 35388616 Get It

AbstractMicroglia have fundamental roles in health and disease; however, effects of age, sex, and genetic factors on human microglia have not been fully explored. We applied bulk and single‐cell approaches to comprehensively characterize human microglia transcriptomes and their associations with age, sex, and APOE. We identified a novel microglial signature, characterized its expression in bulk tissue and single‐cell microglia transcriptomes. We discovered microglial co‐expression network modules associated with age, sex, and APOE‐ε4 that are enriched for lipid and carbohydrate metabolism genes. Integrated analyses of modules with single‐cell transcriptomes revealed significant overlap between age‐associated module genes and both pro‐inflammatory and disease‐associated microglial clusters. These modules and clusters harbor known neurodegenerative disease genes including APOE, PLCG2, and BIN1. Meta‐analyses with published bulk and single‐cell microglial datasets further supported our findings. Thus, these data represent a well‐characterized human microglial transcriptome resource and highlight age, sex, and APOE‐related microglial immunometabolism perturbations with potential relevance in neurodegeneration.
Influences of Adenosine Transporter Antagonism on Vasodilator Responses to Adenosine and Exercise in Humans
Martin, Élizabeth , Ceridon, Maile L., Nicholson, Wayne T. , Charkoudian, Nisha , Joyner, Michael J.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 20 | Issue: 4 | Pages: No page available

10.1096/fasebj.20.4.a814-b Get It

We previously demonstrated a bimodal distribution of vasodilator responsiveness to adenosine (ADO) infusion in human subjects: one subgroup demonstrated robust vasodilator responses to ADO (ADO responders) and the other showed blunted responses (non‐responders). Furthermore, ADO receptor antagonism blunted ADO vasodilator responses only in ADO responders and blunted exercise vasodilation only at high workloads in both groups. To test the hypothesis that ADO transporter antagonism would augment vasodilator responsiveness to ADO and exercise only in ADO responders, we compared forearm vasodilation to intra‐arterial infusion of three doses of ADO to vasodilation during three workloads of forearm handgrip exercise before and after ADO transporter antagonism with dipyridamole (DYP) in 10 subjects. In ADO responders (n=5), the change in forearm vascular conductance above baseline (ml min −1 100mmHg −1 ) for the low, medium, and high doses of ADO, respectively, was 61 ± 15, 117 ± 35, 164 ± 47 before DYP and 160 ± 50, 171 ± 59, and 216 ± 87 after DYP. For non‐responders (n=5), these values were 20 ± 2, 36 ± 6, 57 ± 14 before DYP ( P < 0.05 vs. responders) and were 159 ± 40, 293 ± 53, and 377 ± 82 after DYP ( P > 0.05 vs. responders). ADO transporter blockade had no effect on exercise hyperemia in either group ( P > 0.05 for pre vs. post‐DYP). We conclude that there may be increased ADO transporter activity in non‐responders resulting in increased clearance of ADO from the interstitium and that, in both subgroups, ADO is not obligatory for exercise hyperemia.
Transcriptional landscape of human microglia reveals robust gene expression signatures that implicates age, sex and APOE-related immunometabolic pathway perturbations
Carnwath, Troy , Wang, Xue , Allen, Mariet , Lincoln, Sarah, Lewis‐Tuffin, Laura J. , Quicksall, Zachary , Lin, Shu, Tutor‐New, Frederick Q, Ho, Charlotte C.G. , Min, Yuhao , Malphrus, Kimberly G., Nguyen, Thuy , Martin, Elizabeth, Al‐kharboosh, Rawan , Chaichana, Kaisorn L. , Wharen, Robert E. , Guerrero‐Cazares, Hugo , Quiñones‐Hinojosa, Alfredo , Ertekin‐Taner, Nilüfer , Guerrero-Cazares, Hugo , Patel, Tulsi , Garcia, César A. , Grewal, Sanjeet S.

Mayo Clinic

No container title available | June 7, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-523348/v1 Get It

Abstract Microglia have fundamental roles in health and disease, however effects of age, sex and genetic factors on human microglia have not been fully explored. We applied bulk and single cell approaches to comprehensively characterize human microglia transcriptomes and their associations with age, sex and APOE . We identified a novel microglial signature, characterized its expression in bulk data from 1,306 brain samples across 6 regions and in single cell microglia transcriptome. We discovered microglial co-expression network modules associated with age, sex and APOE -ε4 that are enriched for lipid and carbohydrate metabolism genes. Integrated analyses of modules with single cell transcriptomes revealed significant overlap between age-associated module genes and both pro-inflammatory and disease-associated microglial clusters. These modules and clusters harbor known neurodegenerative disease genes including APOE, PLCG2 and BIN1 . These data represent a well-characterized human microglial transcriptome resource; and highlight age, sex and APOE -related microglial immunometabolism perturbations with potential relevance in neurodegeneration.
Does beta‐receptor mediated vasodilation contribute to the augmented blood flow during hypoxic exercise?
Wilkins, Brad W. , Martin, Elizabeth A. , Roberts, Shelly K., Martin, Elizabeth A., Joyner, Michael J.

Mayo Clinic

The FASEB Journal | April 10, 2020 | Volume: 21 | Issue: 5 | Pages: No page available

10.1096/fasebj.21.5.a571-c Get It

Decreased vasoconstrictor responsiveness during hypoxic exercise does not explain the augmented vasodilation in exercising muscle. We tested the hypothesis that β‐mediated vasodilation contributes to a portion of the enhanced muscle blood flow during hypoxic exercise. Subjects breathed hypoxic gas to titrate arterial O 2 saturation to 80% while remaining normocapnic via a re‐breath system. Two consecutive bouts of forearm handgrip exercise (10 and 20% of maximum) were performed under normoxia and hypoxia during saline infusion, during phentolamine (α‐antagoinst) alone and during the combination of phentolamine and propranolol (β‐antagonist). Forearm blood flow (FBF) and blood pressure (MAP) were assessed and forearm vascular conductance (FVC) was calculated (FBF/MAP). Hypoxia alone increased heart rate (62±3 vs. 82±3 bpm) with no change in MAP (86±2 vs. 89±2 mmHg for normoxia and hypoxia respectively). During hypoxic exercise the rise (Δ from baseline) in FVC with phentolamine alone was 166±26 and 448±31 ml/min/100mmHg (10% and 20 % respectively). This rise in blood flow was blunted (143±36 and 279±73 ml/min/100mmHg) with combined phentolamine and propranolol infusion. Thus, preliminary data suggests that in the absence of overlying vasoconstriction, β‐mediated vasodilation may account for a modest portion of the enhanced blood flow during hypoxic exercise.
Acellular Biologic Nipple–Areolar Complex Graft: In Vivo Murine and Nonhuman Primate Host Response Evaluation
Pashos, Nicholas C. , Graham, David M. , Burkett, Brian J. , O’Donnell, Benjamen , Sabol, Rachel A. , Helm, Joshua, Martin, Elizabeth C. , Bowles, Annie C. , Heim, William M., Caronna, Vince C., Miller, Kristin S. , Grasperge, Brooke , Sullivan, Scott K., Chaffin, Abigail E. , Burkett, Brian , Caronna, Vincent C., Bunnell, Bruce A.

Mayo Clinic

Tissue Engineering Part A | January 17, 2020 | Volume: 26 | Issue: 15-16 | Pages: 872-885

10.1089/ten.tea.2019.0222 | PMID 31950890 Get It

O4‐10‐01: CHARACTERIZING CELL TYPE‐SPECIFIC EXPRESSION SIGNATURES IN BRAIN USING SINGLE CELL RNA SEQUENCING
Carnwath, Troy , Lewis‐Tuffin, Laura J. , Allen, Mariet , Lincoln, Sarah, Wang, Xue , Deniz, Kaancan , İş, Özkan , Martin, Elizabeth, Louie, Christopher, Durán, Iván Segura, Wharen, Robert E. , Chaichana, Kaisorn L. , Quiñones‐Hinojosa, Alfredo , Ertekin‐Taner, Nilüfer , Patel, Tulsi , Garcia, César A. , ReFaey, Karim , Guerrero‐Cazares, Hugo

Mayo Clinic

Alzheimer's & Dementia | October 18, 2019 | Volume: 15 | Issue: 7S_Part_24 | Pages: No page available

10.1016/j.jalz.2019.06.4794 Get It

Reassessment of CD62L as a Marker of Pre‐Effector T Cells in the Tumor Draining Lymph Nodes of Head and Neck Cancer Patients
Strome, Scott E. , Flies, Dallas B. , Khurana, Dianne, Salomão, Diva R. , Tamada, Koji , Chapoval, Andrei I. , Kasperbauer, Jan L. , Olsen, Kerry D., Martin, Elizabeth A. , Chen, Lieping

Mayo Clinic

Otolaryngology–Head and Neck Surgery | February 4, 2003 | Volume: 126 | Issue: 2 | Pages: 180-187

10.1067/mhn.2002.122263 | PMID 11870350 Get It

OBJECTIVESCD62L was evaluated as a determinant of human pre‐effector T cells.STUDY DESIGN AND SETTINGPhenotype and cytokine secretion profiles of CD62L cells were determined based on activation status.RESULTSCD62LLow T cells demonstrated significantly higher secretion of interleukin (IL)‐10 and interferon (IFN)‐Γ than did CD62LHigh T cells. After activation, the majority of cells expressed high levels of the CD62L surface marker. Postactivation levels of IL‐10 production remained elevated or unchanged. In a murine B16 melanoma model, freshly isolated CD62LLow tumor draining lymph nodes (TDLN) T cells showed increased secretion of IL‐2 and IL‐4 but not of IL‐10 or IFN‐γ. The surface expression of CD62L and cytokine secretion patterns were maintained after activation with concomitant increases in IL‐10.CONCLUSIONOur results provide evidence that CD62LLow T cells in TDLNs of progressively growing squamous cell carcinoma of the head and neck differ phenotypically and functionally from those of mouse origin.SIGNIFICANCECharacterization of this human CD62LLow T cell population provides initial insight regarding novel surface markers in TDLN T cells that might correlate with antitumor reactivity.